Abstract
HIV and AIDS affect over 30 million people worldwide, and diarrhea affects 28–60% of HIV-positive patients. Patients who have low CD4 counts (less than 350) are highly susceptible to a range of opportunistic infections. Approximately 50% of patients present with an infectious etiology. HIV/AIDS patients are susceptible to bacterial and parasitic causes of diarrhea – cryptosporidiosis being one of the most difficult to treat. Patients should be counseled that ensuring compliance with their protease inhibitors is key in treating their diarrhea.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Logan C, Beadsworth M, Beeching N. HIV and diarrhea: what is new? Curr Opin Infect Dis. 2016;29(5):486–94.
Nwachukwu CE, Okebe JU. Antimotility agents for chronic diarrhoea in people with HIV/AIDS. Cochrane Database Syst Rev. 2008;4:CD005644.
O’Brien ME, Clark RA, Besch CL, Myers L, Kissinger P. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. J Acquir Immune Defic Syndr. 2003;34(4):407–14.
Carcamo C, Hooton T, Wener MH, Weiss NS, Gilman R, Arevalo J, et al. Etiologies and manifestations of persistent diarrhoea in adults with HIV-1 infection: a case-control study in Lima. Peru J Infect Dis. 2005;191(1):11–9.
Silverberg MJ, Gore ME, French AL, Gandhi M, Glebsy MJ, Kovacs A, et al. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the women’s interagency HIV Study. Clin Infect Dis. 2004;5(1):19–24.
Moyle GJ, Youle M, Higgs C, Monaghan J, Prince W, Chapman S, et al. Safety, pharmacokinetics and antiretroviral activity of the poten, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and an extended follow-up in patients infected with human immunodeficiency virus. J Clin Pharmacol. 1998;38:736–43.
Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356:1423–30.
DuPont AU, Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997;92(11):1962.
Call SA, Heudebert G, Saag M, Wilcox CM. The changing etiology of chronic diarrhea in HIV infected patients with CD4 cell counts less than 200 cells/mm3. Amer J Gastroenterol. 2000;95(11):3142–6.
Dikman AE, Schonfeld E, Srisarajivakul NC, Poles MA. Human immunodeficiency virus-associated diarrhea: still an issue in the era of antiretroviral therapy. Dig Dis Sci. 2015;60(8):2236–45.
Cello JP, Day LW. Idiopathic AID enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology. 2009;136:1952–65.
Lew EA, Poles MA, Dieterich DT. Diarrheal diseases associated with HIV infection. Gastroenterol Clin N Am. 1997;26:259–90.
Thoden J, Potthoff A, Bogner JR, et al. Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection. 2013;41(Suppl 2):91–115.
Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis. 2005;40(8):1173–80.
Abubakar I, Aliyu SH, Arumugam C, Hunter PR, Usman NK. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst Rev. 2007;1:CD004932.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gale, A.R., Wilson, M. (2019). Diarrhea and AIDS. In: Graham, A., Carlberg, D.J. (eds) Gastrointestinal Emergencies. Springer, Cham. https://doi.org/10.1007/978-3-319-98343-1_102
Download citation
DOI: https://doi.org/10.1007/978-3-319-98343-1_102
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98342-4
Online ISBN: 978-3-319-98343-1
eBook Packages: MedicineMedicine (R0)